Decision Support in Arizona

Cognito Health is a medical device manufacturer specializing in predictive, contact-free continuous patient monitoring systems for healthcare facilities. Founded in 2012 by physicians and engineers from MIT, Harvard, Stanford, and Taiwan, the company develops AI-powered patient safety solutions designed to reduce hospital-acquired conditions including falls, pressure injuries, and unassisted bed exits. The Cognito Health platform integrates sensor technology with predictive analytics to provide caregivers with actionable, real-time alerts before adverse events occur. Clinical evidence demonstrates up to 43% reduction in patient falls, 71% reduction in pressure injuries, and 92% improvement in nursing efficiency. The scalable solution can be deployed across single units or entire healthcare facilities, supporting acute care, post-acute care, and long-term care settings. The company addresses a significant market need, as falls alone cost U.S. healthcare systems over $50 billion annually. Cognito Health operates globally with offices in the United States and Taiwan, serving hospital systems, rehabilitation centers, and specialized care providers seeking data-driven approaches to patient safety compliance and operational efficiency.

Caris Life Sciences is a precision medicine and AI-driven TechBio company founded in 2008, headquartered in Phoenix, Arizona. The company specializes in molecular profiling and oncology diagnostics, operating a CLIA-certified laboratory that has processed over 1 million cases and 6.5 million tests. Caris develops comprehensive genomic and transcriptomic assays combining whole exome sequencing (WES), whole transcriptome sequencing (WTS), and protein analysis across 23,000+ genes. The company offers two primary clinical offerings: Caris Assure, a blood-based liquid biopsy utilizing circulating nucleic acid sequencing (cNAS) for pan-cancer profiling, and Caris MI Profile, a tissue-based assay delivering DNA, RNA, and protein analysis with AI-predictive algorithms. Caris maintains one of the largest multimodal databases globally—over 740,000 matched molecular and clinical outcomes records—which powers its proprietary Molecular AI platform. This AI engine generates 220+ interpretations and has measured over 50 billion molecular markers. The company serves oncologists, cancer patients, and biopharma partners across the care continuum: disease detection, therapy selection, and treatment monitoring. Caris publishes extensively (1,200+ peer-reviewed publications) and maintains partnerships with 45+ NCI-Designated Cancer Centers and 95+ members worldwide. The platform enables personalized, precision-oncology treatment decisions by revealing molecular blueprints and predicting individual patient response to therapies.

Healthcare Outcomes Performance Company (HOPCo) is the leading orthopedic value-based care organization in the United States, specializing in musculoskeletal (MSK) health outcomes management, service line optimization, and practice management. Based in Phoenix, Arizona, HOPCo operates a comprehensive platform managing the entire continuum of MSK care across orthopedics, spine, pain management, and rehabilitation. The company serves three primary customer segments: MSK practices seeking growth acceleration and sustainable models, health systems pursuing service line optimization and market transformation, and payors implementing population health programs. HOPCo's differentiated platform combines physician-led value-based care programs, advanced medical economics and analytics, clinically integrated networks (including the only URAC-accredited MSK network nationally), and digital patient engagement tools. The company has demonstrated impact in improving clinical outcomes, reducing total cost of MSK care, and enhancing patient access. HOPCo operates across 30+ states with established partnerships among health systems, independent practices, and major payors including Humana.

EchoIQ Limited develops AI-driven clinical decision support software for echocardiography, specifically designed to optimize structural heart damage assessment. The company's flagship platform, EchoSolv AS, leverages measurement-based AI (not image analysis) to deliver rapid, consistent insights from routine echocardiographic measurements. The platform has been developed using one of the world's largest echocardiographic datasets (200+ million measurements) and is FDA-cleared for clinical use. EchoSolv AS is designed to complement clinician review and help identify patients at risk for structural heart conditions such as aortic stenosis, delivering results in seconds at the point of clinical decision. The solution integrates into existing cardiology workflows with minimal disruption, enhancing consistency, efficiency, and throughput in echo laboratories. The company markets to cardiology departments, echo labs, and healthcare systems seeking to standardize measurements and improve diagnostic precision while maintaining clinician control and judgment.

Tech & Health Innovations LLC is a healthcare IT engineering and software solutions company specializing in mission-critical platform development, cloud infrastructure, and AI-driven automation for the healthcare industry. The company provides enterprise-grade software management services including custom development, legacy system modernization, security hardening, and cloud migration (AWS/Azure). Core offerings include a proprietary AI-powered Revenue Cycle Management (RCM) platform with automated billing, predictive denial management, and AI-driven coding audits; digital BPO solutions featuring robotic case processing, digital enrollment, and smart credentialing; and tech-first virtual assistance services with EHR integration and practice management tools. The company maintains SOC2 and HIPAA compliance with 256-bit AES encryption, 99.99% cloud uptime SLA, and <50ms latency across 12 global data centers. Technical capabilities span React, Node.js, Python, AWS/Azure, and Snowflake/SQL. The company serves healthcare systems, medical networks, and health IT providers, with demonstrated success in enterprise cloud migrations (2TB+ clinical data) and AI implementations reducing claim denial rates by 40%. Services are delivered through a combination of custom engineering teams and managed service offerings designed for scalability and interoperability across healthcare continuum systems.